Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 USD | +2.79% | +15.87% | -85.12% |
03-15 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
03-14 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.12% | 2.69M | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+46.79% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- QNRX Stock
- News Quoin Pharmaceuticals, Ltd.
- Cellect Biotechnology : Shareholders OK Merger With Quoin Pharmaceuticals, Sale of Cellect Biotherapeutics Subsidiary